Biomedcode’ s R&D team participated in the activities of the 1st  BSRC Al. Fleming Retreat. R&D projects were presented in three posters and scientific results were discussed with BSRC Al. Fleming scientists. Biomedcode’s overall activities were presented in a regular talk. Read More

Biomedcode is pleased to announce that it has received funding from the European Regional Development Fund of the European Union and Greek national funds through the Operational Program Competitiveness, Entrepreneurship and Innovation, under the call RESEARCH – CREATE – INNOVATE supporting the innovative research network HUPLA that combines the efforts of industrial and renowned academic partners to develop precision drug evaluation tools  for the preclinical development of novel therapies for Multiple Sclerosis and Psoriasis. Read More

Biomedcode is pleased to announce that it has received national funding from the General Secretary for Research and Technology supporting the innovative research networks HUPLA and BreasCaRANKL that combine the efforts of industrial and renowned academic partners to develop precision drug evaluation tools  for the preclinical development of novel therapies for Multiple Sclerosis and Breast Cancer. Read More